ŌURA Secures $200M in Series D Funding to Drive Health Wearable Innovation

ŌURA Secures $200M in Series D Funding to Drive Health Wearable Innovation

ŌURA, the company behind the Oura Ring, has raised $200 million in a Series D funding round, boosting its valuation to $5.2 billion. The round saw participation from Fidelity Management & Research Company and Dexcom, a leader in glucose biosensing.

This new capital will enable ŌURA to expand its product offerings, invest in AI-driven health innovation, and continue global expansion efforts. Additionally, the company plans to explore acquisitions to accelerate growth in the wearable health space. "We’re excited to continue leading innovation while pursuing opportunities beyond the ring," said Tom Hale, CEO of ŌURA.

The funding comes as ŌURA celebrates significant growth, having sold over 2.5 million rings and more than doubled its revenue and member base in the past year. The company has also expanded its retail presence, partnering with Amazon, Target, and military organizations like the U.S. Air Force and Naval Health Research Center.

ŌURA’s recent acquisitions of Sparta Science and Veri, as well as a partnership with Dexcom, have enhanced its health-tracking capabilities. With the launch of the Oura Ring 4, the company continues to advance its focus on sleep, activity, heart health, stress management, and women’s health.

The company’s continued innovation in AI and wearable health tech positions ŌURA to shape the future of personal health monitoring, helping users make informed decisions for a healthier lifestyle.